Nu Skin Enterprises, Inc. (NYSE:NUS) Chairman Steven Lund sold 42,000 shares of Nu Skin Enterprises stock in a transaction dated Wednesday, December 20th. The shares were sold at an average price of $68.11, for a total value of $2,860,620.00. Following the completion of the sale, the chairman now directly owns 4,769 shares in the company, valued at approximately $324,816.59. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.

Steven Lund also recently made the following trade(s):

  • On Friday, December 22nd, Steven Lund sold 108,132 shares of Nu Skin Enterprises stock. The shares were sold at an average price of $68.81, for a total value of $7,440,562.92.

Nu Skin Enterprises, Inc. (NYSE:NUS) opened at $69.97 on Friday. The firm has a market capitalization of $3,800.00, a PE ratio of 25.63, a PEG ratio of 2.47 and a beta of 1.57. The company has a quick ratio of 1.18, a current ratio of 1.78 and a debt-to-equity ratio of 0.44. Nu Skin Enterprises, Inc. has a 1-year low of $47.10 and a 1-year high of $70.27.

Nu Skin Enterprises (NYSE:NUS) last announced its quarterly earnings data on Wednesday, November 1st. The company reported $0.76 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.76. The company had revenue of $563.70 million during the quarter, compared to analysts’ expectations of $562.70 million. Nu Skin Enterprises had a return on equity of 22.38% and a net margin of 6.97%. Nu Skin Enterprises’s revenue for the quarter was down 6.7% compared to the same quarter last year. During the same quarter last year, the company earned $0.98 EPS. sell-side analysts expect that Nu Skin Enterprises, Inc. will post 3.23 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Wednesday, December 6th. Investors of record on Friday, November 17th were issued a dividend of $0.36 per share. This represents a $1.44 dividend on an annualized basis and a yield of 2.06%. The ex-dividend date was Thursday, November 16th. Nu Skin Enterprises’s payout ratio is currently 52.75%.

A number of institutional investors have recently bought and sold shares of the stock. BlackRock Inc. grew its holdings in Nu Skin Enterprises by 1.8% during the second quarter. BlackRock Inc. now owns 6,805,093 shares of the company’s stock worth $427,632,000 after purchasing an additional 121,562 shares during the period. Vanguard Group Inc. grew its holdings in Nu Skin Enterprises by 0.8% during the second quarter. Vanguard Group Inc. now owns 6,060,437 shares of the company’s stock worth $380,838,000 after purchasing an additional 48,805 shares during the period. JPMorgan Chase & Co. grew its holdings in Nu Skin Enterprises by 5.0% during the third quarter. JPMorgan Chase & Co. now owns 1,416,305 shares of the company’s stock worth $87,443,000 after purchasing an additional 66,986 shares during the period. Dimensional Fund Advisors LP grew its holdings in Nu Skin Enterprises by 5.4% during the third quarter. Dimensional Fund Advisors LP now owns 1,125,625 shares of the company’s stock worth $69,204,000 after purchasing an additional 57,750 shares during the period. Finally, Bank of New York Mellon Corp grew its holdings in Nu Skin Enterprises by 22.1% during the second quarter. Bank of New York Mellon Corp now owns 885,257 shares of the company’s stock worth $55,628,000 after purchasing an additional 160,495 shares during the period. Institutional investors and hedge funds own 77.50% of the company’s stock.

Several equities analysts have recently weighed in on NUS shares. Zacks Investment Research cut Nu Skin Enterprises from a “hold” rating to a “sell” rating in a report on Wednesday. ValuEngine upgraded Nu Skin Enterprises from a “hold” rating to a “buy” rating in a report on Tuesday, November 14th. Three investment analysts have rated the stock with a sell rating, two have given a hold rating and four have assigned a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus target price of $62.00.

ILLEGAL ACTIVITY WARNING: This news story was first reported by TheOlympiaReport and is owned by of TheOlympiaReport. If you are reading this news story on another website, it was stolen and reposted in violation of international trademark & copyright laws. The original version of this news story can be read at https://theolympiareport.com/2017/12/24/steven-lund-sells-42000-shares-of-nu-skin-enterprises-inc-nus-stock.html.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.

Insider Buying and Selling by Quarter for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.